| Dosage Form: | Injections |
| Function: | Ophthalmic operation |
| Validity: | 24 Months |
| Component: | hyaluronate acid |
| CAS: | 9067-32-7 |
| Transparency (0.1% Solution): | 99%min 99.10% |
| pH(0.1%Water Solution): | 6.5-7.5 |
| Function: | Ophthalmic Remedy |
| Payment Terms: | L/C,T/T |
| Minimum Order Quantity: | 30 Piece/Pieces |
| Supply Ability: | 20000 Piece/Pieces per Week |
| Package: | SYRINGE: B&D GLASS SYRINGE WITH LUER LOK TIP FOR SCREW CONNECTION OF THE CANNULA CANNULA: B&D 23G/25G / 27G ( depending product performance ) PACKING: EASY TO OPEN BLISTER PACKING AT CORNER OF THE BLISTER LABELS: 1. LABEL AT SYRINGE 2. LABEL AT BLISTER (as your order) |
| Delivery Time: | within 25days after contact |
Ophthalmic Equment Hyaluronate Acid (HA) adopts high-purity refined medical hyaluronate acid (HA) and is a kind of ideal ...
Ophthalmic Equment Hyaluronate Acid (HA) adopts high-purity refined medical hyaluronate acid (HA) and is a kind of ideal adjuvant to ophthalmic surgery. With the average molecular weight of 1~2.4 millions, it contains 1-2% medical sodium hyaluronate, has good kinematic viscosity, little deviation, and sufficient functions of forming anterior chamber and protecting corneal endothelium. The substance is a kind of high-viscoelasticity, sterile, non-pyrogenic, and nonantigenic macromolecular polysaccharide biomaterial. The preparation is packed in pre-filling and pre-sealing injector, which is easy to operate in surgery
Functions and Mechanisms: viscoelastic liner function, pseudoplastic function, tissue isolation function, and viscous blockage function
Application Scope: intracapsular and extracapsular cataract extraction, keratoplasty, glaucoma surgery, retinal decollement, phacoemulsification, ocular trauma surgery and ocular surgery.
Specifications: 0.5ml/piece, 0.8ml/piece, and 1ml/piece.